BCBS Arkansas Medical Policy Updates – January 2023

Click here to view the Blue Cross Blue Shield BCBS Arkansas Medical Policy Updates »

January 2023 BCBS Arkansas Medical Policy Updates:

• Ambulatory Blood Pressure Monitoring
• Antineoplaston Cancer Therapy
• Anti-PD-1 (programmed death receptor-1)Therapy (Pembrolizumab)(Nivolumab)
• Aqueous Shunts and Devices for Glaucoma
• Asfotase alfa (Strensiq®)
• Atezolizumab (Tecentriq)
• Autism Spectrum Disorder, Early Behavioral Intervention
• Belantamab mafodotin-blmf (Blenrep™)
• Biofeedback as a Treatment of Fecal Incontinence or Constipation
• Bone Growth Stimulation, Electrical, Appendicular Skeleton
• Bortezomib (e.g., Velcade)
• Brachytherapy, Prostate, High-Dose Rate Temporary
• Cabotegravir ER inj susp (e.g., Apretude)
• Cardiovascular Risk Panels
• Computed Tomography (CT) Scanning for Lung Cancer Screening
• Digital Health Technologies: Diagnostic Applications
• Direct Acting Antiviral Medications for Treatment of Chronic Hepatitis C
• Efgartigimod (e.g., Vyvgart)
• Electric Breast Pump (Hospital Grade)
• Electronic Brachytherapy for Nonmelanoma Skin Cancer
• Fam-trastuzumab deruxtecan-nxki (Enhertu®)
• Gastroesophageal Reflux Disease (GERD), Magnetic Esophageal Ring
• Gene Therapies for Thalassemia: Betibeglogene autotemcel (e.g., Zynteglo)
• Genetic Test: Analysis of MGMT Promoter Methylation in Malignant Gliomas
• Genetic Test: Cancer Susceptibility Panels Using Next Generation Sequencing
• Genetic Test: Carbamazepine HLA-B*1502
• Genetic Test: Cardiac Ion Channelopathies (Long QT Syndrome, Brugada Syndrome, CPVT, Short QT Syndrome)
• Genetic Test: Colon Cancer, KRAS, NRAS and BRAF Mutation Analysis to Determine Tumor Sensitivity to Chemotherapy
• Genetic Test: Fecal DNA to Detect Colorectal Cancer, Screening
• Genetic Test: Hypertrophic Cardiomyopathy, Predisposition
• Genetic Test: Neurofibromatosis
• Genetic Test: X-Linked Opitz G/BBB Syndrome, MID1 Mutation Testing
• HDC & Hematopoietic Stem Cell Support-Miscellaneous Solid Tumors in Adults
• High Dose Chemotheraphy with Allogenic or Autologous Stem Cell and/or Progenitor Cell Support
• Hyperbaric Oxygen Pressurization (HBO)
• Intensity Modulated Radiation Therapy (IMRT), Anus, Anal Canal
• Iron Therapy, Parenteral
• Lab Test: Identification of Microorganisms Using Nucleic Acid Probes
• Lurbinectedin (ZepzelcaTM)
• Lyme Disease Intravenous Antibiotic Therapy and Associated Diagnostic Testing
• Measurement of Exhaled Nitric Oxide and Exhaled Breath Condensate the Diagnosis and Management of Asthma and Other Respiratory Disorders
• Measurement of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in the Assessment of Cardiovascular Risk
• Medical Technology Assessment, Non-Covered Services
• Moxetumomab pasudotox-tdfk* (e.g., LUMOXITI)
• Multispectral Digital Skin Lesion Analysis (MelaFind®) (MSDSLA)
• Patient-actuated End Range Motion Stretching Devices
• Percutaneous Transluminal Endovascular Graft for Abdominal Aortic Aneurysm
• PET or PET/CT for Anal Carcinoma
• PET or PET/CT for Small Cell Lung Cancer
• PET or PET/CT for Testicular Germ Cell Cancer
• PET or PET/CT for Uterine Cancer
• PET Scan for Multiple Myeloma, Plasmacytoma
• PET Scans (Positron Emission Tomography)
• PET Scans (Positron Emission Tomography)
• PET Scans (Positron Emission Tomography)
• PET Scans (Positron Emission Tomography)
• PET Scans (Positron Emission Tomography)
• Photodynamic Therapy for Dermatologic Conditions
• Preventive Services for Non-Grandfathered (PPACA) Plans: Abdominal Aortic Aneurysm Screening
• Preventive Services for Non-Grandfathered (PPACA) Plans: Aspirin for the Prevention of Morbidity and Morality from Preeclampsia in High Risk Pregnant Women
• Preventive Services for Non-Grandfathered (PPACA) Plans: Breast Cancer Preventive Medication
• Preventive Services for Non-Grandfathered (PPACA) Plans: Breast Cancer Screening (Mammography)
• Preventive Services for Non-Grandfathered (PPACA) Plans: Colorectal Cancer Screening
• Preventive Services for Non-Grandfathered (PPACA) Plans: Overview
• Radiofrequency Ablation and Other Laparoscopic and Percutaneous Techniques for the Myolysis of Uterine Fibroids
• Sensory Integration Therapy and Auditory Integration Therapy
• Sipuleucel-T (Provenge) for the Treatment of Prostate Cancer
• Skin and Soft Tissue Substitutes, Bio-Engineered Products
• Spinal Decompression Therapy (Internal Disc Decompression Therapy, Spinal Distraction Therapy) Using Motorized and/or Computerized Traction
• Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Gamma Knife Surgery, Linear Accelerator, Cyberknife, TomoTherapy
• Surgery for Morbid Obesity
• Telemedicine
• Transesophageal Endoscopic Therapies for Gastroesophageal Reflux Disease
• Trastuzumab AND Trastuzumab and Hyaluronidase-oysk
• Tumor Antigen, Prostate Specific Antigen (PSA)
• Wireless Capsule Endoscopy as a Diagnostic Technique in Disorders of the Small Bowel, Esophagus and Colon
• Ziv-aflibercept (Zaltrap)

Click here to view the Blue Cross Blue Shield BCBS Arkansas Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.